Inogen Inc 8-K

What Happened

• Inogen, Inc. filed a Current Report on Form 8-K dated February 24, 2026 to disclose two items: (1) the company issued a press release reporting financial results for the fourth quarter and full year ended December 31, 2025, and (2) the Board approved a share repurchase program authorizing up to $30 million of the company’s common stock. The press releases were furnished as Exhibits 99.1 and 99.2 to the 8-K. The filing was signed by Michael Bourque, Executive Vice President and Chief Financial Officer.

Key Details

• The earnings press release covers results for the quarter and year ended December 31, 2025 (press release dated February 24, 2026; see Exhibit 99.1).
• Board approved repurchase program authorized up to $30.0 million in aggregate purchases of common stock (approved February 20, 2026; announced February 24, 2026; see Exhibit 99.2).
• Repurchases may be executed on the open market, in compliance with Rule 10b-18 and through Rule 10b5-1 trading plans; the program expires on the earlier of December 31, 2027 or when the $30M limit is used.
• The repurchase program does not obligate the company to buy shares and may be modified, suspended or terminated at any time.

Why It Matters

• The 8-K confirms Inogen has reported its latest quarterly and full-year results — investors should review the February 24, 2026 press release (Exhibit 99.1) for actual revenue, profit, and other financial metrics.
• The $30 million buyback gives management flexibility to reduce outstanding shares, which can support per-share metrics and earnings-per-share if executed; timing and extent of repurchases will depend on cash, market conditions and legal limits.
• The program’s approval and the reported results are material corporate actions that can influence investor sentiment and the company’s capital allocation profile; shareholders should read the attached press releases for full details.